Sign up to all DiabetesontheNet journals
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
Meta-analysis suggests SGLT2 inhibitors are associated with a 46% lower risk of renal failure compared with other diabetes drugs.
6 Jun 2023